Phage display technology is one of the methods widely adopted for the production of human monoclonal antibodies. The subject of the present research was the scFv -single chain variable fragment antibody -which was able to recognize the D 2 -5-HT 1A heteromer formed by dopamine D 2 and serotonin 5-HT 1A receptors. The antibody was selected using the phage display technique and the human antibody scFv phagemid library Tomlinson J. We investigated two expression systems: prokaryotic and eukaryotic. The results indicate that both of these systems (E.coli HB2151 and High Five cells (BTI-TN-5B1-4) of Trichopulsia ni) are suitable for the production of scFv antibodies, but the scFvs obtained from insect cells could attain a higher protein concentration. Next, we examined a few purifi cation methods: immobilized-metal affi nity chromatography (IMAC), affi nity chromatography with the c-myc tag and the methods using protein L or A agarose, which are applicable to scFvs lacking tags. In the bacterial as well as insect cell expression systems, protein L agarose chromatography gave satisfactory results, and in our opinion, it is the best choice as a purifi cation resin. Additionally, circular dichroism measurements confi rmed the predominant content of secondary structures in the tested antibodies, which is consistent with the literature data.
Introduction
ScFvs (single chain variable fragment) are small antibody fragments composed of immunoglobulin-heavy (VH) and light chain-variable (VL) regions with a fl exible peptide linker designed to connect the two chains such that the antigen binding site is retained in a single co-linear molecule [1] . Currently scFvs antibodies attract a lot of attention due to their potential usage in pharmacology and diagnostic fi elds [2] [3] [4] . The properties of this kind of antibodies make them an attractive modality for pharmaceutical development, especially in areas such as cancer and autoimmune diseases in which cell-cell interactions or ligand-receptor interactions play a crucial role in the pathogenesis [5] . Moreover, scFvs are very useful nanoprobes for the targeted delivery of drugs to specifi c cells or tissues since they can be successfully used as targeting ligands for the functionalization of nanocarriers [6] . In comparison to the much larger Fab, F(ab) 2 , and IgG forms of the monoclonal antibodies from which they are derived, scFvs have lower retention times in non-target tissues, more rapid blood clearance, better tissue penetration and reduced immunogenicity, making them attractive for therapeutic applications [7] . ScFvs antibodies can be derived from phage display libraries [8, 9] . Phage display technology (based on the signifi cant work of Smith, 1985) [10] is an in vitro screening technique that allows rapid selection of multiple monoclonal antibodies of high affi nity and specifi city [11] . The nature of the method enables the rapid and effi cient identifi cation of specifi c binders, as well as greater control over the selection parameters that facilitate the isolation of antibodies with unique, desirable functional characteristics [5] .
Very often, scFvs contain poly-His or/and c-myc tags that are used in their purifi cation and identifi cation in vitro. Many protocols describe scFv production and purifi cation in specifi c expression systems, including bacteria, yeast, plant, insect, and mammalian cells, as well as in transgenic animals [12] [13] [14] [15] .
Depending on the expression system, their ability to fold and secrete the scFv proteins varies [16] .
In this report, we investigated two expression systems: prokaryotic and eukaryotic. We present the results from the preparation of scFv expressed in E.coli HB2151 and High Five cells (BTI-TN-5B1-4) of Trichopulsia ni. Prokaryotic expression systems have several advantages including low cost of production and the ability to produce large amounts of recombinant proteins in short periods of time, but their main drawback is the accumulation of aggregated material in the cytoplasm, known as inclusion bodies. On the other hand, a signifi cant advantage of insect cells is their capability to perform most posttranslational modifi cations used by higher eukaryotes, such as glycosylation, phosphorylation, acylation and palmitylation [17] . In the present work, we focused on developing a simple, fast and effi cient method for the purifi cation of soluble scFv fragments. We examined a few purifi cation methods: immobilized-metal affi nity chromatography (IMAC), which is only applicable to scFvs containing a poly His-tag; affi nity chromatography with the c-myc tag; and the methods using protein L or A agarose, which are applicable to scFvs lacking tags. The subject of the research was scFvs antibodies specifi cally recognizing D 2 -5-HT 1A heteromer (dimer formed by dopamine D 2 and serotonin 5-HT 1A receptors) selected using the phage display technique and the human antibody scFv phagemid library Tomlinson J.
The presented results have been collected for at least several various scFv proteins whose common characteristic was selectivity against D 2 -5-HT 1A membrane proteins. Although we described data only for different types of scFvs antibodies selective for one type of heteromer, the presented results were similar also for other types of scFvs antibodies obtained against other various membrane receptors (data not shown). We choose scFvs against D 2 -5-HT 1A heteromer for publication as a representative case since it would be diffi cult to show results for all proteins which were obtained in our lab and it would make the work unreadable and confusing. Bearing in mind diffi culties in obtaining scFv specifi cally recognizing dimers of membrane receptors the statistical attempt and data collected in the presented work seem to be interesting and may be a good starting point in designing similar experiments.
Materials and Methods

Selection of human monoclonal scFv antibody
Human monoclonal scFvs antibodies were selected using the phage displayed library Tomilson J (Geneservise) which was amplifi ed and titrated according to the manufacturer's protocols using E. coli TG1 cells. In total, 1.9x1013 individual clones were CHO-) were used) and fi nally 2 negative selections were performed. Before protein expression, the cDNAs of scFvs from the selected phages were isolated and sequenced to check for the presence of STOP codons inside the coding sequence.
Prokaryotic expression system
To obtain soluble scFv expressed in E. coli, HB2151 (Novagen) cells were transformed with selected vector plasmids. A single colony was used to inoculate 5 ml of 2xYT medium+Amp (100 μg/ml) (Lab Empire), and the cultures were grown overnight at 37°C. A 0.5 ml portion of the overnight culture was used to inoculate 25 ml of medium, and then this culture was used to start a 1L culture at 37°C. Expression was induced in the host bacteria by adding IPTG (Sigma-Aldrich) to a fi nal concentration of 1 mM when the OD 600 reached 0.9. Cells were cultured for 16 h at 28°C, and then the cells were harvested by centrifugation (4000 g, 15 min, 4°C). The cells were placed on ice until the purifi cation of scFv procedure was started.
Eukaryotic expression system
The production of scFv in eukaryotic cells was conducted 
Expression level analysis
After scFv expression obtained periplasmatic fraction from E.coli HB2151 as well as cell lisates from High Five cells were analysed by ELISA technique using affi nity of the scFv (Tomilson J) fragments to protein A. Protein A resuspended in PBS buffer (1 μg/ml) was added to each well of 96-well plate (50 μl per well) and incubated overnight at 4°C. Then the plate was blocked using 2 % BSA solution (1 h, 37°C) and 50 μl of investigated samples (periplasmatic fraction or cell lysates) were added to appropriate wells and incubated at 37°C for 1 h.
The washing step was conducted 3 times 200 ml PBS. Then 50 ml of protein L conjugated with HRP (protein L was resuspended in 0.5% BSA/PBS at a 1:2000 ratio) (GE Healthcare) was added to the wells and incubated for 30 min at 37°C. After washing (carried out 4 times as described above), the reactions were developed by TMB substrate (GE Healthcare). Experiments were performed in triplicate.
scFv purifi cation
ScFvs derived from E.coli and insect cells were purifi ed at room temperature, but the buffers used were ice-cold. buffer) fi lled with Ni-IDA 1000 (Macherey-Nagel), a fraction of periplasmic protein was applied (at fl ow rate 1.0 ml/min).
Bacterial expression system:
Subsequently, the weakly bound proteins were washed away (1xLEW buffer, 5 x column volume, fl ow rate 1.5 ml/min), and elution was performed using a mixture of 1xLEW + 10 mM imidazole buffer and 1xLEW + 250 mM imidazole buffer with an imidazole gradient (up to 250 mM imidazole) (at a fl ow rate of 1.5 ml/min). From the fractions obtained after elution, samples for SDS-PAGE were prepared. The protein concentration was determined using the Bradford method. The fractions in which the presence of protein was found were dialyzed against 1xPBS and frozen at -80°C. 
SDS-PAGE and Western blotting:
Samples for analysis were mixed with 2x electrophoresis buffer containing 50 mM TrisHCl at pH 6.8, 10% glycerol, 2% SDS, 0.1% bromophenol blue and 5% -mercaptoethanol and heated for 5 min at 95°C. SDS-PAGE was performed according to Laemmli (1970) [18] , with a 4% stacking gel and a 12% resolving gel (Mini-Protean 3, BioRad). Gels were stained by Coomassie Brilliant Blue. 
Analysis of the specifi city of the obtained scFvs monoclonal antibodies
The specifi city of the purifi ed scFvs was determined by ELISA. One hundred ml aliquots of purifi ed antibodies at different concentrations resuspended in 4% BSA were incubated for 1.5 h at 37°C in 96-V-well plate. Then, 1. 
Results and Discussion
Phage display technology is a very useful tool for the isolation of target-specifi c monoclonal antibodies. Unfortunately, the relatively fast selection process does not always coincide with the fast expression and purifi cation of the protein. There are a number of different strategies (such as bacterial cells [19, 20] , mammalian cells [21] , yeast [22] , plant cells [23] , and insect cells [24] ) used to express scFv antibody fragments.
The proteins can be expressed as correctly folded and directly active proteins or as aggregates requiring in vitro refolding to become active [16] . There are some general regulations to consider in the design of vectors and expression systems used with the different hosts, and each of the hosts has advantages and disadvantages for the production of active scFv antibodies [17, 25] . Additionally, a wide range of methodologies has been adapted for successful purifi cation of the given protein [17] .
Nevertheless, success depends to a large extent on the properties of the antibody itself, which we are not able to predict in the early stages of selection. A problem that often accompanies the preparation of antibodies is their instability. Because of the nature of scFv fragments, this kind of antibody is less stable than the whole antibody. For example, immunoglobulin G (IgG) is a heterotetrameric molecule consisting of two heavy and two light chains connected via disulfi de bonds. Heavy and light chains (HC and LC) also contain intramolecular disulfi de bonds for stabilization [26] . In comparison, scFv consists only of variable (V) regions, and it possesses a soluble and fl exible amino acid peptide linker which connects the V regions [7] and one disulfi de bond for stabilization.
Because of the problems mentioned above, in the present work, we focused on the comparison of some strategies used to produce and purify soluble scFv antibodies. Two different expression systems -bacterial and insect cells -were adopted for this purpose. In both cases, (E.coli and insect cells), scFvs antibodies were successfully obtained (Figure 1 ). There are three locations from which bacterially expressed proteins can be isolated: the cytoplasm, the periplasm, and the culture supernatant. Many studies showed that the majority of proteins are expressed as insoluble inclusion bodies in the cytoplasm of E.coli [27, 28] . The purifi cation of inclusion bodies is often interconnected with denaturation and refolding, which is problematic as far as the production of active soluble scFv antibodies is concerned [16] . In this study, soluble scFv antibodies were expressed in non-suppressive E. coli HB2151 bacteria cells. There is a termination codon between the phage pIII gene and the scFv gene. When the phage infects nonsuppressive E. coli HB2151 cells, the termination codon will be translated. Therefore, the scFv gene will not be expressed as a fusion protein with pIII in HB2151 cells, but it will be expressed as the soluble protein and secreted into the periplasmic zone.
In the E. coli expression system, the periplasmic compartment is preferably used for recombinant protein production. There appears to be much less protease activity in the periplasmic space than in the cytoplasm. In addition, scFv antibodies purifi cation is simpler due to fewer contaminating proteins in the periplasm. Another advantage is that the correct formation of disulfi de bonds can be facilitated in this location because the periplasmic space provides a more oxidative environment than does the cytoplasm, and it is rich in proteins which are important for folding and catalysing disulfi de bond formation (PDI, DsbA and DsbC) or chaperones [29, 30] .
On the other hand, the use of a baculovirus expression system is a promising way to produce molecules for therapeutic which enables one to use blue-white screening to isolate the recombinant bacmid DNA [31] . This kind of in vivo transposition guaranties 100% effi ciency in producing recombinant baculovirus DNA, and this approach, known as the Bac-to-Bas system, was used in this study. A baculovirus carrying cDNA of scFV antibody was created and amplifi ed in Sf9 cells. The high-titer baculovirus was used to infect High Five cells, which are considered to be more effi cient at producing recombinant antibodies than Sf9 cells [32] . In preliminary experiments, both the multiplicity of infection and the time of cell growth after infection were tested. These optimization steps showed that satisfactory scFv production was achieved when the MOI (multiplicity of infection) amounted to 5 and cells were grown for 48 hours after infection. In conclusion, this stage of the studies showed that both investigated expression systems are suitable for scFv production.
In the next step, we compared a few methods of the purifi cation of scFvs expressed as soluble proteins in E. coli and insect cells using affi nity chromatography. Application of different methodologies available for antibody purifi cation is widespread, as underlined in some thematic papers, e.g. [33] [34] [35] . Protein L agarose purifi cation is a one-step purifi cation method that yields signifi cant amounts of pure 
Conclusion
The speed, along with the in vitro nature of the selection process and the ability to produce human antibodies, makes phage display a very potent technology for the generation of scFvs antibodies suitable for therapeutic development [5] .
However, despite the numerous benefi ts of the methods, problems associated with obtaining soluble and active forms of proteins often arise. Therefore, in the present work, we compared prokaryotic and eukaryotic expression systems for the production of soluble scFv antibodies. Both systems are useful tools. In both the bacterial and insect cell expression systems, protein L agarose chromatography gave satisfactory results, and in our opinion, it is the best choice as a purifi cation resin. 
